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Abstract
Dysbindin-1, a protein that regulates aspects of early and late brain development, has 
been implicated in the pathobiology of schizophrenia. As the functional roles of the 
three major isoforms of dysbindin-1, (A, B and C) remain unknown, we generated a 
novel mutant mouse, dys-1A
-/-
, with selective loss of dysbindin-1A and investigated 
schizophrenia-related phenotypes in both males and females. Loss of dysbindin-1A 
resulted in heightened initial exploration and disruption in subsequent habituation to a 
novel environment, together with heightened anxiety-related behavior in a stressful 
environment. Loss of dysbindin-1A was not associated with disruption of either long-
term (olfactory) memory or spontaneous alternation behavior. However, dys-1A
-/- 
showed enhancement in delay-dependent working memory under high levels of 
interference relative to controls, i.e. impairment in sensitivity to the disruptive effect 
of such interference. These findings in dys-1A
-/-
 provide the first evidence for 
differential functional roles for dysbindin-1A vs dysbindin-1C isoforms among 
phenotypes relevant to the pathobiology of schizophrenia. Future studies should 
investigate putative sex differences in these phenotypic effects.   
Ͷ
INTRODUCTION
Dystrobrevin-binding protein 1 (DTNBP1), more commonly known as dysbindin-1, is 
a protein with diverse physiological roles that extend particularly to the nervous 
system, where it regulates aspects of early and late brain development and neuronal 
functions that include gene transcription, axonal and dendritic spine formation, 
receptor trafficking, synaptic vesicle biogenesis and exocytosis (Talbot et al., 2009; 
Jia et al, 2014; Mullin et al, 2015). This protein is of special clinical interest given 
that variation in the DTNBP1 gene has been associated with risk for schizophrenia 
(Allen et al, 2008; Ayalew et al, 2012) and that DTNBP1 gene and/or protein 
expression are down-regulated in multiple brain regions [i.e., the hippocampal 
formation (HF: Talbot et al, 2004, 2011; Weickert et al, 2008), dorsolateral prefrontal 
cortex (PFC: Weickert et al, 2004; Tang et al, 2009), and auditory association cortices 
(Talbot et al, 2011)] of schizophrenia cases. These regions are essential elements in a 
hippocampal-prefrontal cortical network that is implicated in the regulation not only 
of memory, emotion and other self-referential processes (Aggleton, 2012) but also of 
putative sexually dimorphic cognitive dysfunction in schizophrenia (Mendrek and 
Mancini-Marie, 2015). Indeed, the role of dysregulated dysbindin-1 gene and protein 
expression in schizophrenia appears most closely related to the prominent cognitive 
impairment in that disorder since DTNBP1 genotype influences cognition both in 
normal subjects and in schizophrenia (Burdick et al, 2007; Zinkstok et al, 2007; 
Zhang et al, 2010; Wolf et al, 2011; Baek et al, 2012; Varela-Gomez et al, 2015).  
       While reductions of one or more dysbindin-1 isoforms have been found in the 
brains of schizophrenia cases (Talbot et al, 2004, 2009, 2011; Tang et al, 2009), it 
remains unclear what contributions each of these isoforms may make to increased risk 
ͷ
and clinical features of schizophrenia. Three major dysbindin-1 isoforms are 
expressed in the human brain: dysbindin-1A, -1B, and -1C (Talbot et al, 2009, 2011). 
Dysbindin-1A (~ 50 kDa) is the full-length protein (351 amino acids in humans), is 
localized in synapses almost entirely postsynaptically in humans (Talbot et al, 2011), 
and is a component of a large protein assembly known as BLOC-1 (biogenesis of 
lysosomal organelles complex-1; Larimore et al, 2014; Wang et al, 2014). Dysbindin-
1B (~ 37 kDa) is a truncated version of dysbindin-1A (303 amino acids in humans) in 
which the C-terminal region lacks the PEST domain of dysbindin-1A (Talbot et al, 
2009). This second isoform, which is not expressed in mice, is localized in synapses 
only presynaptically (Talbot et al, 2011), and may or may not be part of BLOC-1. 
Dysbindin-1C (~33 kDa) is also a truncated version of dysbindin-1A (270 amino 
acids in humans), but the truncation occurs in the N-terminal region (NTR), which is 
entirely missing in dysbindin-1C (Talbot et al, 2009). This third isoform is localized 
in synapses both pre- and post-synaptically (Talbot et al, 2011; Wang et al, 2014) and 
is not part of BLOC-1 (Larimore et al, 2014; Wang et al, 2014).  
       Mouse mutants have been used to identify functions of dysbindin-1 isoforms and 
their potential contributions to schizophrenia phenotypes. The mouse most intensively 
studied for this purpose is the sandy (sdy) mouse, which arose from a spontaneous 
deletion mutation of exons 6 and 7 (along with most of introns 5-7) in the DTNBP1 
gene (Li et al, 2003; Talbot, 2009; Talbot et al, 2009). This leads to expression of 
DTNBP1 transcripts encoding a truncated coiled-coil region on which all dysbindin-1 
isoforms depend for interaction with other proteins (Talbot et al, 2009). These 
abnormal transcripts are not successfully translated. Thus, while wildtype (WT) mice 
express dysbindin-1A and -1C (but not dysbindin-1B as indicated above), 
homozygous sdy (dys
-/-
) mice express neither isoform (Talbot, 2009; Talbot et al, 
͸
2009). As a result, abnormalities found in sdy mice are not readily attributable to loss 
of any specific dysbindin-1 isoform. 
       As noted above, dysbindin-1A differs from dysbindin-1C by the presence of the 
NTR in the former isoform. The NTR is encoded by exons 1 and 3-5, partial or 
complete deletion of which should produce transcripts without the NTR and thus 
encode only dysbindin-1C (Talbot et al, 2009). The ability to distinguish between 
effects of dysbindin-1A and -1C is important given their differences in synaptic 
localization and presence in BLOC-1, as well as their differences in protein 
interactions and physiological functions (Talbot et al, 2009). Dysbindin-1A is the 
dysbindin isoform best known to regulate gene expression in developing and adult 
neurons (Oyama et al, 2009; Larimore et al, 2014; Soma et al, 2014) and differs from 
dysbindin-1C by having a binding site for Akt (Talbot et al, 2009), which mediates 
promotion of neuronal viability by dysbindin-1A (Nakamura et al, 2004). In contrast, 
dysbindin-1C has neuronal functions separate from dysbindin-1A, including 
promotion of autophagy (Yuan et al, 2015), regulation of adult neurogenesis in the 
dentate gyrus (Wang et al, 2014), and potential suppression of vagally-induced 
apoptosis in the hippocampus (González-López et al, 2013). 
       In rodent brain, levels of dysbindin-1A (~ 50 kDa) are highest at late embryonic 
and early postnatal periods (Ghiani et al, 2010; Ito et al, 2010), while levels of 
dysbindin 1C (~ 33 kDa) are barely detectable before early adulthood (Ito et al, 2010). 
We report here that selective knockout of exon 5 in the DTNBP gene of C57Bl/6J 
mice results in selective loss of dysbindin-1A without reduction of dysbindin-1C 
levels in the brain. We studied the behavioral phenotype in both male and female 
dysbindin-1A mutants given that sex influences schizophrenia incidence risk (greater 
in males: Aleman et al, 2003; McGrath et al, 2008; Abel et al, 2010; van der Werf et 
͹
al, 2014) and peak age at onset (later in females: Häfner et al, 1998; van der Werf et 
al, 2014) and that schizophrenia risk associated with some genetic variants in 
DTNBP1 differs according to sex (Zuo et al, 2009; Voisey et al, 2010; Sacchetti et al, 
2013; Tan et al, 2015). Accordingly, adult male and female heterozygous and 
homozygous mutants and WT mice were evaluated to determine phenotypic effects 
on a wide range of sensorimotor, schizophrenia-related and other behaviors. By 
providing the first characterization of the dysbindin-1A-null phenotype, the present 
paper provides the first indications of the contributions dysbindin-1A reductions may 
make to the pathophysiology of schizophrenia.  
MATERIALS AND METHODS 
Animals
Male and female breeding pairs and experimental mice were housed in opaque plastic 
cages (30 × 16 × 12 cm). Standard laboratory mouse chow and water were available 
ad libitum. Mice were maintained at a constant temperature of 21 ± 1º C on a 12-h 
light/dark schedule. Offspring were left with breeding pairs until they reached 
weaning age of 19-22 days. Experimental animals were generated from heterozygous 
breeding pairs selected from different litters. Once genotyped, mice were housed in 
groups of 3-5 per cage. Male and female WT and mutant mice were from litters of the 
same generational age and were studied during young adulthood in groups of 
indistinguishable current age. All experiments were approved by the Research Ethics 
Committee of the Royal College of Surgeons in Ireland under license from the 
ͺ
Department of Health and Children, in accordance with Irish legislation and the 
European Communities Council Directive 86/609/EEC for the care and use of 
experimental animals, and from the Environmental Protection Agency in relation to 
the contained use of genetically modified organisms. 
Construction and Validation of Exon 5-DTNBP1 Knockout Mice 
We generated a novel mutant mouse with deletion in exon 5 of the DTNBP1 gene and 
resultant isoform-specific loss of brain expression of dysbindin-1A protein, hereafter 
referred to as dys-1A
-/-
, together with heterozygous mutants (dys-1A
+/-
) and WT (dys-
1A
+/+
). Gene targeting was performed in C57Bl/6J KSR5.4 embryonic stem cells. 
Male chimaeras were crossed with C57Bl/6J females to produce N1F0 offspring. Null 
alleles were generated by crossing animals containing the primary targeted allele with 
a germline Cre deleter transgenic strain (SA-Cre: Taconic-Artemis, Germany). 
Heterozygous animals carrying the null allele were mated with one another to produce 
F1 animals. PCR genotyping was performed using WT and targeted allele-specific 
primers. Detailed descriptions of the construction and genotyping of this mutant line 
are given in Supplementary Information. 
To confirm isoform-specific knockout, dysbindin-1A and -1C proteins were 
evaluated by Western-blot analysis using a fully validated and well-characterized 
antibody (Oxford PA3111; Benson et al, 2001; Talbot et al, 2009, 2011). Western 
blots were analysed by densitometry using ImageJ software (NIH, Bethesda, MD). A 
detailed description of these procedures is given in Supplementary Information. 
General Health and Sensorimotor Function 
ͻ
Mice were evaluated for any general health problems and sensorimotor deficits that 
might interfere with performance in behavioral tasks, using multiple assessments from 
previously described procedures: Comprehensive Observational Assessment (Irwin, 
1968) and SHIRPA (SmithKline Beecham, Harwell, Imperial College, Royal London 
Hospital phenotype assessment; Rogers et al, 1997). A detailed description of these 
assessments is given in Supplementary Information Table S1.  
Exploratory Activity 
Automated analysis of exploratory activity in a novel environment was conducted as 
described previously (O'Tuathaigh et al, 2010). A detailed description of this 
behavioral assay is given in Supplementary Information.
Anxiety-Related Behavior 
Elevated plus-maze. The elevated plus-maze was used to test anxiety-related behavior, 
as described previously (O'Tuathaigh et al, 2010). A detailed description of this 
behavioral assay is given in Supplementary Information.
Light/dark box. Anxiety-related behavior was also assessed in the light-dark box, as 
described previously (O'Tuathaigh et al, 2012). A detailed description of this 
behavioral assay is given in Supplementary Information.
Prepulse Inhibition 
ͳͲ
Habituation of startle response and prepulse inhibition was assessed as described 
previously (O'Tuathaigh et al, 2012). A detailed description of this behavioral assay is 
given in Supplementary Information.
Social Behavior 
Sociability and social novelty preference. The three-chamber test of sociability and 
social novelty was conducted as described previously (O'Tuathaigh et al, 2008). A 
detailed description of this behavioral assay is given in Supplementary Information.
Dyadic social interaction. Using ethologically-based indices of social behavior, 
dyadic social interaction with an unfamiliar conspecific was evaluated as described 
previously (O'Tuathaigh et al, 2008). A detailed description of this behavioral assay is 
given in Supplementary Information.
Long-Term (Olfactory) Memory 
Long-term olfactory memory was assessed using the social transmission of food 
preference test, employing a previously described protocol (Wrenn et al, 2003). A 
detailed description of this behavioral assay is given in Supplementary Information.
Spontaneous alternation behavior 
The Y-maze was used in a continuous spontaneous alternation procedure, inter alia a 
putative index of delay-independent working memory (Dudchenko, ʹͲͲͶȌ, as 
ͳͳ
described previously (O'Tuathaigh et al, 2010). A detailed description of this 
behavioral assay is given in Supplementary Information.
Delay/Interference-Dependent Working Memory 
In the 8-arm radial maze, a delayed non-match-to-position paradigm (Dudchenko, 
2004; Malleret et al, 2010) was employed; the procedure involved a low working 
memory load with two levels of interference: limited interference or high interference. 
A detailed description of this behavioral assay is given in Supplementary Information.
Statistical Analysis  
This followed procedures similar to those described previously (O'Tuathaigh et al,
2010). Multivariate analysis of variance (ANOVA) was applied to assess group 
differences. Repeated measures ANOVA was performed for exploratory behavior, 
behavior in the light/dark box, prepulse inhibition, social behavior, and behavior in 
the radial arm maze. Where the data were not normally distributed, analyses were 
conducted following square-root transformation. Statistically significant effects in 
each ANOVA were followed by post-hoc comparisons using the Least Significant 
Difference test. As the present studies on dys-1A
-/-
 mice were conducted using both 
males and females, findings are presented for each sex separately. All results are 
presented as means ± SEM. A p value < 0.05 was considered significant. Statistical 
analyses were performed using the Statistical Package for the Social Sciences 
program 19.0 (SPSS, Chicago, IL). 
ͳʹ
RESULTS 
Selective Loss of Dysbindin-1A Expression in Dys-1A
-/-
Dysbindin-1A (~ 50 kDa) was expressed in the hippocampal formation and 
cerebellum of WT but was reduced in dys-1A
+/-
 and absent in dys-1A
-/-
. In contrast, 
expression of dysbindin-1C (40 kDa) in the hippocampal formation was evident 
across all genotypes (Figure 1). We confirmed findings in both humans and mice 
(Talbot et al, 2009, 2011; Wang et al, 2014) by showing that dysbindin-1C expression 
is at or below the threshold of detectability in the cerebellum, irrespective of genotype.  
General Health and Sensorimotor Function 
No general health problems or sensorimotor deficits were detected in dys-1A
-/-
, 
including ability to nest, deliver pups and provide milk to offspring, basic visual, 
auditory and olfactory function, pain sensitivity and motor coordination. As observed 
in relation to the sdy mutant, the dys-1A
-/-
 coat color is sandy due to the fact that 
absence of dysbindin-1A should interfere with BLOC-1 function, one of which is 
synthesis of melanin (Li et al, 2003). As with the sdy mutant, dys-1A
-/- 
also exhibited 
prolonged bleeding time following tail biopsy, due to platelet abnormalities (Li et al, 
2003). No other overt phenotypic abnormalities were observed (Supplementary 
Information Table S1).   
Dysregulation of Novelty-Induced Exploration and Habituation in Dys-1A
-/-
ͳ͵
On day 1, male dys-1A
-/-
 mice showed locomotor hyperactivity during initial 
exposure to the novel environment of the open field, but habituated rapidly within this 
initial session (time × genotype interaction: F(6,34) = 3.12, p < 0.01; dys-1A
-/-
 mice 
travelled a greater distance than WT mice during the first 5 min of exposure, p < 
0.05); no significant effects were evident among females (Figure 2a,b). On repeated 
exposure to the open-field, male dys-1A
-/-
 mice showed hyperactivity during the first 
5 min of exposure across days 1-4 (effect of genotype: F(2,34) = 4.87, p = 0.01; dys-
1A
-/-
 mice travelled a greater distance than WT mice during the first 5 min of 
exposure on day 1, p < 0.05, and day 2, p < 0.001); no significant effects were evident 
among females (Figure 2c,d). The level of habituated locomotor activity following 
completion of assessment on day 4 was indistinguishable between the genotypes for 
both sexes (Figure 2e,f). Following a 4-day retention interval and re-exposure to the 
open-field on day 8, activity during the first 5 min of exposure across days 4-8 was 
increased among male dys-1A
-/- 
mice (effect of genotype: F(2,34) = 3.77, p < 0.05; 
dys-1A
-/-
 mice travelled a greater distance than WT mice during the first 5 min of 
exposure on day 8, p < 0.05); no significant effects were evident among females 
(Figure 2g,h).  
In summary, an increase in novelty-induced exploratory activity was observed in 
male but not female dys-1A
-/-
. 
Dysregulation of Anxiety-Related Behavior in Dys-1A
-/-
In the elevated plus-maze, the total number of entries into either arm did not differ 
between the genotypes for either sex (Supplementary Information Figure S1a,b). 
Female dys-1A
-/-
 mice spent the majority of time in the closed arms, a minority of 
ͳͶ
time in the middle area and little time in the open arms, in a manner that differed 
between the genotypes (compartment × genotype interaction: F(4,90) = 3.74, p < 
0.01; dys-1A
-/-
 mice spent more time in the closed arms, p < 0.05, and less time in the 
center area, p < 0.05); no significant effects were evident among males (Figure 3a,b). 
To further characterize these findings, we evaluated ethological behaviors that have 
been shown to not only enhance discrimination between general activity and 
emotional reactivity but also enhance the sensitivity of the test to anxiety-related 
behavior (Carobrez and Bertoglio, 2005). Female dys-1A
-/-
 mice made fewer head-
dips in the center hub (effect of genotype: F(2,30) = 3.36, p < 0.05; dys-1A
-/- 
mice 
made fewer head-dips than WT mice, p < 0.05), a decision point for 
approach/avoidance conflict, with no alteration in stretched-attend postures in the 
center hub or in the number of closed arm returns or rearing-to-wall in the closed 
arms (data not shown); no significant effects were evident among males (Figure 3c,d).  
In the light/dark box, on initial exposure to the apparatus, female dys-1A
-/-
 mice 
spent less time in the light compartment (effect of genotype: F(2,29) = 3.37, p < 0.05; 
during the first 5-min period, dys-1A
-/- 
mice spent less time in the light compartment 
than WT mice, p < 0.01), with no genotypic difference in distance travelled as an 
index of locomotor activity (Figure 3e,g); no significant effects were evident among 
males (Figure 3f, h). 
In summary, across two measures of anxiety-related behavior, an increase in 
anxiety was observed in female but not male dys-1A
-/-
. 
ͳͷ
Prepulse Inhibition  
Reactivity to stimuli increased with both prepulse and pulse intensities, and 
habituated between block 1 and block 2 of the procedure, in a manner that did not 
differ between the genotypes (Supplementary Information Figure S2a-h). The only 
genotypic finding was that at pulse intensity 100 dBA male dys-1A
+/-
 mice, but not 
dys-1A
-/-
 mice, showed reduced % PPI (prepulse intensity × genotype interaction: 
F(4,52) = 4.44, p < 0.001; no significant effects were evident among males (Figure 
4a-f). While there are precedents for phenotypic effects in mice heterozygous but not 
homozygous for other mutations (Gogos et al, 1998; Babovic et al, 2008), as 
neither %PPI nor the internal control indices of responsivity to prepulse or pulse 
intensities alone and habituation to pulses were altered in either male or female dys-
1A
-/-
 mice, there appeared to be no fundamental disruption to the sensorimotor gating 
processes that underlie PPI in mice with the null mutation.  
In summary, under one specific pulse intensity condition, a deficit in PPI was 
observed in male but not female dys-1A
+/-
, and not in dys-1A
-/-
, relative to all other 
groups. 
Social Behavior 
On assessment of sociability, both male and female spent the majority of time in the 
chamber containing Stranger 1, a minority of time in the opposite, empty chamber and 
little time in the center area, in a manner that did not differ between the genotypes 
(Supplementary Information Figure S3a,b). On subsequent assessment of social 
novelty preference, both males and females switched preference to spend the majority 
ͳ͸
of time in the chamber containing the newly introduced Stranger 2, a minority of time 
in the opposite chamber containing the now familiar Stranger 1 and little time in the 
center area, in a manner that did not differ between the genotypes (Supplementary 
Information Figure S3c,d). On assessment of dyadic social interaction, for both males 
and females the number of olfactory investigations, time spent in olfactory 
investigations, number of walkovers and time spent in walkovers did not differ 
between the genotypes (data not shown).  
In summary, there appeared to be no genotype-related disruption to social 
behavior that involves either indirect or direct interaction with a conspecific. 
Long-Term (Olfactory) Memory 
On assessment of social transmission of food preference, male and female mice ate 
more food cued by the demonstrator than non-cued food at 24 h and at 7 days 
following interaction with the demonstrator, in a manner that did not differ between 
the genotypes (Supplementary Information Figure S4a-d). 
Spontaneous Alternation Behavior 
On assessment in the Y-maze, for both males and females, each of spontaneous 
alternation performance, percentage alternate-arm returns and percentage same-arm 
returns did not differ between the genotypes (Supplementary Information Figure S5a-
f).  
ͳ͹
Dysregulation of Delay/Interference-Dependent Working Memory in Dys-1A
-/-
In the low-interference working memory task using the radial maze, the number of 
correct choices increased with training trials during acquisition for both sexes (males, 
effect of trial: F(5,70) = 4.48, p < 0.001; females, effect of trial: F(5,115) = 2.71, p < 
0.05), followed by a delay-dependent decrease in number of correct choices (males, 
effect of trial: F(4,56) = 6.23, p < 0.001; females, effect of trial: F(492) = 3.66, p < 
0.01), in a manner that did not differ between the genotypes (Figure 5a,b).  
In the high-interference working memory task, number of correct choices again 
increased with training trials during acquisition for both sexes (males, effect of trial: 
F(5,70) = 2.47, p < 0.05; females, effect of trial: F(5,115) = 3.71, p < 0.01), in a 
manner that did not differ between the genotypes. However, in male dys-1A
-/-
 mice 
the delay-dependent decrease in number of correct choices differed between the 
genotypes (effect of trial: F(4,56) = 6.58, p < 0.001; effect of genotype: F(2,56) = 
10.46, p < 0.01; dys-1A
-/-
 made more correct choices than WT at the 55-s delay, p < 
0.01); in female dys-1A
-/-
 the delay-dependent decrease in number of correct choices 
(effect of trial: F(4,92) = 4.56, p < 0.01) did not differ between the genotypes (Figure 
5c,d).  
In summary, male but not female dys-1A
-/-
 showed enhancement in delay-
dependent working memory under high levels of interference relative to controls, i.e. 
impairment in sensitivity to the disruptive effect of such interference. 
ͳͺ
DISCUSSION
We have demonstrated that targeted knockout of DTNBP1 exon 5 in mice on a 
C57BL/6J background results in a novel dys-1A
-/-
 mutant mouse with selective loss of 
dysbindin-1A protein expression.  This is in contrast to the DTNBP1 mutation that 
arose spontaneously in the DBA2/J mouse and was later back-crossed into C57Bl/6J 
mice, which results in loss of both dysbindin-1A and -1C (Talbot, 2009). Thus, the 
present studies in dys-1A
-/-
 mutants inform, for the first time, on the functional roles 
of dysbindin-1A in schizophrenia-related and other phenotypes.
Heightened Initial Exploratory Behavior in Dys-1A
-/-
 Mice 
This finding related primarily to the very early phase of the interaction of dys-1A
-/-
mutants with the novel environment and subsequent habituation. The hyper-
exploratory response to novelty, a predictive model of positive psychotic symptoms in 
schizophrenia (van den Buuse, 2010), appears to involve transient enhancement of 
perception and arousal, with early triggering of the mesocorticolimbic system to 
promote release of dopamine in the HF (Schomaker and Meeter, 2015). That the 
present findings were evident primarily in males would be consistent with evidence, 
from lower organisms through rodents to humans, that exploratory drive is stronger in 
males, in a manner that involves hippocampal more than accumbal processes (Clinton 
et al, 2011; Cross et al, 2013; Videlier et al, 2015). Recent studies in patients with 
schizophrenia, the majority of whom were male, have likewise reported over-activity 
in a novel, human open-field paradigm, with disruption to habituation of initial 
exploratory activity (Perry et al., 2009, 2010). Several DTNBP1 genetic variants 
ͳͻ
(usually SNPs) in introns 1, 3, 4, and/or 7 are more closely associated with 
schizophrenia risk in males than in females, either increasing (Voisey et al, 2010; Tan 
et al, 2015) or decreasing (Zuo et al, 2009; Sacchetti et al, 2013) risk depending on 
the specific variants. If the genetic variants associated with increased risk for 
schizophrenia in males affect expression of exon 5 and thus dysbindin-1A, this could 
relate to the novelty-induced exploratory activity observed in male dys-1A
-/-
. If so, 
this may reflect an inhibitory role of dysbindin-1 on exploratory drive, and potentially 
other sexually dimorphic features of schizophrenia, and may help explain why males 
show a higher incidence, younger age at onset, and more severe psychopathology in 
schizophrenia (Aleman et al, 2003; McGrath et al, 2008; Abel et al, 2010; van der 
Werf et al, 2014).  
Heightened Anxiety-Related Behavior in Dys-1A
-/-
 Mice 
This finding was robust across two anxiogenic paradigms. The anxiety response to 
stress appears to involve functional neuronal networks in which local circuits transfer 
information across different brain areas in an integrative manner, including the 
amygdala, PFC, ventral HF and nucleus accumbens (Luthi and Luscher, 2014). That 
the anxiety response was significant only in females is consistent with evidence from 
rodents and humans that anxiety-related behaviors are more evident in females due in 
part to baseline and stress-induced hypothalamic-pituitary-adrenal axis responses that 
involve the brain areas mentioned above (Simpson and Kelly, 2012; Altemus et al,
2014; Luthi and Luscher, 2014). Thus, dysbindin-1A may play an inhibitory role in 
these processes in females. Anxiety is a prominent comorbid psychopathology in 
schizophrenia, more commonly than in the general population, where it is more 
ʹͲ
evident in females than in males (Braga et al, 2013; Pallanti et al, 2013; Altemus et al,
2014). It is unknown if related effects in dys-1A
-/-
 reflect effects of DTNBP1 genetic 
variants in introns 1 and 4 that affect risk for schizophrenia more in females than 
males, either positively (Zuo et al, 2009) or negatively (Sacchetti et al, 2013) 
depending on the specific genetic variant. 
Dysregulation of Specialized Delay/Interference-Dependent Working Memory in 
Dys-1A
-/-
 Mice 
While long-term (olfactory) memory, spontaneous alternation behavior, and delay-
dependent working memory under low levels of interference were unaltered, dys-1A
-/-
showed enhancement in delay-dependent working memory under high levels of 
interference relative to controls, i.e. impairment in sensitivity to the disruptive effect 
of such interference, revealing a highly specialized role for dysbindin-1A in cognition. 
The PFC has long been implicated in working memory processes (Fuster, 2000), 
including delay-period activity (Liu et al, 2014), and in the cognitive dysfunction of 
schizophrenia (Keefe and Harvey, 2012). Recent evidence indicates a role for parallel 
processing of information between PFC and HF in such functions for shorter delay 
times, with the balance shifting towards involvement of HF with increasing delay 
(Malleret et al, 2010). Therefore, the present findings suggest an important role for 
dysbindin-1A in regulating the sensitivity of delay-dependent working memory to 
higher levels of interference. This process has been shown to involve plasticity in the 
DG (Malleret et al, 2010), with a particular role for neurogenesis (Saxe et al, 2007), 
including circuit-dependent integration of immature neurons in effective DG function 
(Rangel et al, 2013). Schizophrenia cases show diminished vulnerability to proactive 
ʹͳ
interference due to their greater loss of previous working memory traces and 
disruption of coupling between PFC and subcortical (limbic/thalamic) regions, shown 
with functional imaging (Anticevic et al, 2012; Kaller et al, 2014), that would confer 
greater autonomy to temporal lobe regions. 
The fact that these cognitive abnormalities were significant only in males may be 
consistent with reports noted earlier that some genetic variants in DTNBP1 modify 
risk for schizophrenia in males more than in females (Zuo et al, 2009; Voisey et al,
2010; Sacchetti et al, 2013; Tan et al, 2015). As also noted earlier, these variants are 
in non-coding regions of the DTBP1 gene, specifically introns 1, 3-4, and/or 7 close 
to exons encoding the NTR of dysbindin-1A (i.e. exons 1 and 3-5; Talbot et al, 2009). 
In contrast to other locations in the gene, variability in these NTR-associated 
DTNBP1 introns is associated with early-onset psychosis (Gornick et al, 2005; Fatjo-
Villas et al, 2011) and cognitive impairment in schizophrenia (Zinkstok et al, 2007; 
Wessman et al, 2009; Zhang et al, 2010). 
Comparing Behavioral Phenotypes in Dys-1A
-/-
 and sdy
-/-
 Mice 
The present findings include genotypic effects that are present in one sex but not in 
the other, and it is now recommended that sex differences in biological effects should 
be assumed until proven otherwise (McCarthy, 2015). Though these can be attested 
by significant genotype × sex interactions, that they here fall short of a conventional 
level of statistical significance likely reflects that detection of such interactions 
requires sample sizes approximately 4× those needed to detect main effects. Thus, 
confirmation of sex differences in phenotypic effects awaits studies with larger 
sample sizes. 
ʹʹ
Differential functions of dysbindin-1A vs dysbindin-1C are suggested by 
comparing the present findings with those on sdy
-/-
 mice, which lack both dysbindin-
1A and -1C (Talbot, 2009; see Supplementary Information Table S2 for comparative 
summary of behavioral phenotypes studies in mostly male sdy mutants and the 
present dys-1A mutants of both sexes). The many indices of sensorimotor function 
tested here proved to be normal in dys-1A
-/- 
mice, as they are in sdy
-/-
 mice on either a 
DBA/2J (sdy/DBA; Takao et al, 2008) or a C57Bl/6J (sdy/Bl6; Cox et al, 2009; 
Papaleo et al, 2012) background, as well as in mice selectively overexpressing human 
dysbindin-1A (Shintani et al, 2014). Unlike female dys-1A
-/-
 mice, there is no clear 
evidence for increased anxiety in female sdy
-/-
/Bl6 mice (Cox et al, 2009). Unlike 
male dys-1A
-/-
 mice, there is evidence to suggest increased anxiety in male sdy
-/-
/DBA 
mice under extended testing conditions (Hattori et al, 2008). Also, unlike male dys-
1A
-/-
 mice, male sdy
-/-
/BL6 mice show impaired prepulse inhibition (Carlson et al, 
2011; Papaleo et al, 2012), and sdy
-/-
/DBA mice show reduced social interactions 
(Hattori et al, 2008; Feng et al, 2008). However, these apparent differences require 
further investigation, because only one study has been published on the behavior of 
female sdy
-/-
/Bl6 mice (Cox et al, 2009) and because the specific tests of working 
memory studied here have not been examined in sdy
-/-
 mice. Also, sdy
-/-
 mice have 
not been evaluated for long-term (olfactory) memory, which we found to be normal in 
dys-1A
-/-
 mice. 
Comparison of dys-1A
-/- 
and sdy
-/-
 mice suggests that the behavioral roles of 
dysbindin-1A are more subtle than those of dysbindin-1C. This may reflect the 
finding in mice that levels of dysbindin-1A are lower than those of dysbindin-1C in 
many forebrain areas, including the cerebral cortex and HF (Ito et al, 2010; Wang et 
al, 2014). Of the three brain areas of schizophrenia cases investigated for dysbindin-1 
ʹ͵
isoforms, reductions in dysbindin-1A have been found in auditory association cortices 
of the superior temporal gyrus (Talbot et al, 2011), whereas reductions in dysbindin-
1C have been found in the dorsolateral PFC (Tang et al, 2009) and HF (Talbot et al, 
2011). 
The more subtle behavioral abnormalities of dys-1A
-/-
 compared to sdy
-/-
 mice 
provides a more selective model of certain aspects of schizophrenia. Among these is 
BLOC-1 reduction in this disorder, as dysbindin-1A (but not dysbindin-1C) is 
essential for the integrity of BLOC-1 (Li et al, 2003; Larimore et al, 2014; Wang et al, 
2014), other components of which are markedly reduced in brains of schizophrenia 
cases (Talbot et al, in preparation). BLOC-1 reductions may help explain aspects of 
synaptic dysfunction in schizophrenia, since they impair synaptic protein trafficking 
and vesicle release (Mullin et al, 2011, 2015).  
The dys-1A
-/-
 mutant may also be a more selective model of auditory dysfunction 
associated with dysbindin-1 reductions in schizophrenia than is the sdy
-/-
 model, as 
dysbindin-1A, but not dysbindin-1C, is reduced in auditory association cortices of 
schizophrenia cases (Talbot et al, 2011). Several DTNBP1 SNPs are associated with 
auditory, visual, and olfactory hallucinations in schizophrenia, two of which are in 
linkage disequilibrium with a DTNBP1 SNP reported to reduce expression of the 
dysbindin-1A gene (Cheah et al, 2015). In sdy
-/-
 mice, which lack both dysbindin-1A 
and -1C, auditory cortices in general are atrophic (Lutkenhoff et al, 2012) and 
dysfunctional (Carlson et al, 2011). Future studies should thus examine the auditory 
cortices of dys-1A
-/-
 mice to determine the consequences of selective dysbindin-1A 
loss in these brain areas. In summary, the present findings in dys-1A
-/-
 mice on a 
C57Bl/6J background provide the first evidence for selective functional roles for 
dysbindin-1A vis-a-vis dysbindin-1C among phenotypes relevant to the pathobiology 
ʹͶ
of schizophrenia. Future studies should investigate putative sex differences in these 
phenotypic effects. 
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FIGURE LEGENDS 
Figure 1 (a) Adapted representation of dysbindin-1A, -1B and -1C from Talbot et al
(2009). Compared to the full long isoform dysbindin-1A, dysbindin-1B has a shorter 
CTR and dysbindin-1C lacks the NTR that is encoded by exons 1 and 3-5. (b) 
Selective abrogation of dysbindin-1A is obtained by the formation of ES cells with 
DTNBP1 exon 5-targeted disruption. Exogenous DNA is introduced into ES cells 
from C57BL/6 mice via homologous recombination. Recombinant cells in which one 
copy of the DTNBP1 gene is disrupted was obtained by using a recombinant vector 
that carries the DTNBP1 gene disrupted with neo
r
, a neomycin-resistance gene. 
Subsequently, homologous recombination in neomycin resistant ES cells was 
confirmed by Southern blot. (c) Western blots showing expression of dysbindin-1A 
(50 kDa) and dysbindin-1C (40 kDa) in wildtype (WT, dys-1A
+/+
) mice and mice with 
heterozygous (dys-1A
+/-
) or homozygous (dys-1A
-/-
) deletion of dysbindin-1A, using 
Oxford PA3111 antibody, with α-actin (100 kDa) as loading control. In the 
hippocampus, expression of dysbindin-1A is reduced in dys-1A
+/- 
and absent in dys-
1A
-/-
, while expression of dysbindin-1C is intact across all genotypes. Similarly, in the 
cerebellum expression of dysbindin-1A is reduced in dys-1A
+/- 
and absent in dys-1A
-/-
, 
while expression of dysbindin-1C was essentially absent across all genotypes. A faint 
second band below 40 kDa has been noted previously in WT mice and may 
correspond to a dysbindin-1C degradation product (Talbot et al, 2009).   
Figure 2 Novelty-induced exploration and habituation in 25 WT (dys-1A
+/+
; 13 male, 
12 female), 24 dys-1A
+/- 
(12 male, 12 female) and 22 dys-1A
-/-
 (12 male, 10 female) 
mice. Data are presented as means ± SEM. (a) and (b): Distance travelled on day 1 in 
ʹ͸
males and females, respectively, during the four successive 5-min periods constituting 
a 20-min exposure to the open-field; *p < 0.05 male dys-1A
-/-
vs WT. (c) and (d): 
Distance travelled on days 1  4 in males and females, respectively, during initial 5-
min periods of exposure to the open-field on successive days; ***p < 0.001, *p < 0.05 
male dys-1A
-/-
vs WT. (e) and (f): Distance travelled on day 4 in males and females, 
respectively, during the four successive 5-min periods constituting the 20-min 
exposure to the open-field. (g) and (h): Distance travelled on day 4 and, following a 
retention interval of four days, on re-introduction to the open-field on day 8 in males 
and females, respectively, during initial 5-min periods of exposure to the open-field 
on each day; *p < 0.05 male dys-1A
-/-
vs WT.  
Figure 3 Anxiety-related behavior in 24 WT (dys-1A
+/+
; 13 male, 11 female), 24 dys-
1A
+/- 
(12 male, 12 female) and 23 dys-1A
-/-
 (13 male, 10 female) mice. Data are 
presented as means ± SEM. (a) and (b): %Time spent in the open and closed arms and 
center hub (middle) area of the elevated plus-maze during the 5-min test period; *p < 
0.05 female dys-1A
-/-
vs WT. (c) and (d): Number of head-dips (HD) in the center hub 
during the 5-min test period; *p < 0.05 female dys-1A
-/-
vs WT. (e) and (f): %Time 
spent in the light compartment of the light/dark box during each of two successive 5-
min periods constituting a 10-min test; *p < 0.05 female dys-1A
-/-
vs WT. (g) and (h): 
Distance travelled in the light/dark box during each of two successive 5-min periods 
constituting a 10-min test. 
Figure 4 Prepulse inhibition (PPI) in 23 WT (dys-1A
+/+
; 11 male, 12 female), 20 dys-
1A
+/- 
(8 male, 12 female) and 19 dys-1A
-/-
 (10 male, 9 female) mice. Data are 
presented as means ± SEM. (a) and (b): %PPI in mice subjected to prepulses of 4, 8 
ʹ͹
and 16 dBA at pulse intensity 100 dBA; ***p < 0.001 male dys-1A
+/-
vs WT. (c) and 
(d): %PPI in mice subjected to prepulses of 4, 8 and 16 dBA at pulse intensity 110 dBA. 
(e) and (f): %PPI in mice subjected to prepulses of 4, 8 and 16 dBA at pulse intensity 
120 dBA.
Figure 5 Delay-dependent working memory in 16 WT (dys-1A
+/+
; 6 male, 10 female), 
15 dys-1A
+/- 
(5 male, 10 female) and 12 dys-1A
-/-
 (6 male, 6 female) mice. Data are 
presented as means ± SEM per 2-day block of trials. (a) and (b): Number of correct 
choices in the radial arm maze during acquisition trials (B1-6) and trials with 
increasing delay (20-75 (s)) under conditions of low interference. (c) and (d): 
Number of correct choices in the radial arm maze during acquisition trials (B1-6) and 
trials with increasing delay (20-75 (s)) under conditions of high interference; ***p < 
0.001 male dys-1A
-/-
vs WT. 
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